<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jawad MU</submitter><funding>NIH HHS</funding><pagination>5475</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9501210</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(18)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Cutaneous soft-tissue sarcoma (CSTS) of the head and neck are rare and are known to have aggressive clinical course. The current study utilizes a population-based registry in the U.S. to characterize these malignancies and explore disparities.&lt;h4>Methods&lt;/h4>National Cancer Institute's (NCI) Surveillance, Epidemiology and End Result (SEER) database from 2000 to 2018 was queried to report incidence and survival data in 4253 cases in the U.S.&lt;h4>Results&lt;/h4>Males were 5.37 times more likely and Non-Hispanic-White people (NHW) were 4.62 times more likely than females and Non-Hispanic-Black people (NHB) to develop CSTS of the head and neck. The overall incidence was 0.27 per 100,000 persons in 2018, with a significant increase since 2000. Advanced age and stage, histologic group other than 'fibromatous sarcoma' and lower SES groups were independent factors for worse overall survival.&lt;h4>Conclusions&lt;/h4>CSTS of the head and neck demonstrate sex and racial/ethnic disparities in incidence and socioeconomic disparities in overall survival.&lt;h4>Level of evidence&lt;/h4>II.</pubmed_abstract><journal>Journal of clinical medicine</journal><pubmed_title>Head and Neck Cutaneous Soft-Tissue Sarcoma Demonstrate Sex and Racial/Ethnic Disparities in Incidence and Socioeconomic Disparities in Survival.</pubmed_title><pmcid>PMC9501210</pmcid><funding_grant_id>#5K12-CA138464</funding_grant_id><pubmed_authors>Zeitlinger LN</pubmed_authors><pubmed_authors>Randall RL</pubmed_authors><pubmed_authors>Traven SA</pubmed_authors><pubmed_authors>Monjazeb AM</pubmed_authors><pubmed_authors>Canter RJ</pubmed_authors><pubmed_authors>Bewley AF</pubmed_authors><pubmed_authors>Thorpe SW</pubmed_authors><pubmed_authors>O'Donnell EF</pubmed_authors><pubmed_authors>Carr-Ascher JR</pubmed_authors><pubmed_authors>Jawad MU</pubmed_authors></additional><is_claimable>false</is_claimable><name>Head and Neck Cutaneous Soft-Tissue Sarcoma Demonstrate Sex and Racial/Ethnic Disparities in Incidence and Socioeconomic Disparities in Survival.</name><description>&lt;h4>Background&lt;/h4>Cutaneous soft-tissue sarcoma (CSTS) of the head and neck are rare and are known to have aggressive clinical course. The current study utilizes a population-based registry in the U.S. to characterize these malignancies and explore disparities.&lt;h4>Methods&lt;/h4>National Cancer Institute's (NCI) Surveillance, Epidemiology and End Result (SEER) database from 2000 to 2018 was queried to report incidence and survival data in 4253 cases in the U.S.&lt;h4>Results&lt;/h4>Males were 5.37 times more likely and Non-Hispanic-White people (NHW) were 4.62 times more likely than females and Non-Hispanic-Black people (NHB) to develop CSTS of the head and neck. The overall incidence was 0.27 per 100,000 persons in 2018, with a significant increase since 2000. Advanced age and stage, histologic group other than 'fibromatous sarcoma' and lower SES groups were independent factors for worse overall survival.&lt;h4>Conclusions&lt;/h4>CSTS of the head and neck demonstrate sex and racial/ethnic disparities in incidence and socioeconomic disparities in overall survival.&lt;h4>Level of evidence&lt;/h4>II.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-27T01:56:42.459Z</modification><creation>2025-04-06T18:24:17.007Z</creation></dates><accession>S-EPMC9501210</accession><cross_references><pubmed>36143122</pubmed><doi>10.3390/jcm11185475</doi></cross_references></HashMap>